Holen Sie sich die Stockscreener-App
77.86
3.06%
-2.46
Handel nachbörslich:
78.72
0.86
+1.10%
Finanzdaten der Dianthus Therapeutics Inc-Aktie (DNTH)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
28.28%
0.284
|
0.396 | 0.193 | 1.163 | 1.326 |
Operating Expenses
|
71.63%
69.83
|
40.68 | 35.12 | 34.34 | 33.24 |
| Benefits Costs and Expenses |
64.72
|
- | - | 30.67 | 29.77 |
| Costs And Expenses |
59.07%
64.72
|
40.68 | 35.12 | 30.67 | 16.35 |
| Operating Income/Loss |
72.61%
-69.54
|
-40.29 | -34.93 | -33.18 | -31.92 |
| Nonoperating Income/Loss |
45.02%
5.109
|
3.523 | 3.298 | 3.666 | 3.476 |
| Income/Loss From Continuing Operations Before Tax |
16,371%
-64.43
|
0.396 | -31.63 | -29.51 | -28.44 |
| Income/Loss From Continuing Operations After Tax |
75.25%
-64.43
|
-36.77 | -31.63 | -29.51 | -28.44 |
|
Net Income/Loss
|
75.25%
-64.43
|
-36.77 | -31.63 | -29.51 | -28.44 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
94.33%
2.1412
|
37.79 | 35.82 | 35.79 | 0.6991 |
| Diluted Average Shares |
94.33%
2.1412
|
37.79 | 35.82 | 35.79 | 0.6991 |
| Basic Earnings Per Share |
56.70%
-1.52
|
-0.97 | -0.88 | -0.82 | -0.82 |
| Diluted Earnings Per Share |
56.70%
-1.52
|
-0.97 | -0.88 | -0.82 | -0.82 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):